India DMAPA Prices Fall 2.63% MoM in January Amid Demand Slowdown

India’s Dimethylaminopropylamine (DMAPA) market moved lower in January as demand softened after the year-end retail rush and buyers worked down inventories. Early January saw local DMAPA producers hold ex-works offers steady with routine operating rates and uninterrupted natural-gas supply. By mid-month, formulators trimmed spot purchases to manage December stock and delayed GST credits, while late-January trading showed greater interest in imported Chinese and European cargoes as domestic availability struggled to fully cover consumption. Overall, sellers’ attempts to pass rising upstream costs met buyer resistance, leaving DMAPA quotations under downward pressure throughout the month.

Sector dynamics helped shape the decline: personal-care demand was soft as cocamidopropyl betaine formulators reduced purchases for shampoos and liquid soaps, while agrochemical offtake stayed weak amid a post-Rabi lull and the start of pre-emptive Kharif procurement. In contrast, steady activity in pharmaceutical synthesis and water-treatment applications (poly DADMAC) provided a base level of...